Expert Interviews

Elizabeth Holt, MD, FACE and Eden Miller, DO, comment on saving time for the provider and giving patients ownership of their data as benefits of using digital BGM apps in the management of diabetes.

Immunize.org's Dr Kelly Moore says that without clear surveillance data on RSV, particularly on hospitalizations, clinicians may hesitate to commit office resources to administration.

Low awareness of RSV in adults and misperceptions about the goal of vaccination aren't new challenges, says Kelly Moore, MD, MPH, Immunize.org president and CEO.

Medical director of the NFID William Schaffner, MD, discusses the research behind the FDA's decision to approve the first-ever RSV vaccine.

A nationally recognized obesity expert discusses mental health in women with obesity.

Immunize.org president and CEO Kelly Moore, MD, MHP, describes the holistic view the ACIP will take of the virus, the vaccine, and the overall economics of the immunization.

Kelly Moore, MD, MPH, says the public health community is relieved by the FDA's approval and excited at "the chance to finally do something about the disease."

Eden Miller, DO, highlights a lack of knowledge in both the patient and the prescriber as a barrier to effective use of BGM technology in diabetes, as well as the need for personalized care for patients.

Elizabeth Holt, MD, FACE, provides an overview of a study on patients with diabetes using the OneTouch Verio Flex meter, a blood glucose meter (BGM) and OneTouch Reveal, a diabetes-management digital app, in tandem.

Scott Laker, MD, vice president of the AAPM&R, offers 3 thoughts on what primary care clinicians should think of when they think about PM&R.

Dr Caroline Apovian reminds primary care clinicians who care for patients with obesity that diet and lifestyle counseling are essential for maximum results.

The partnership between primary care and PM&R is a tool in each specialty's tool box, with the patient's return to full function the shared goal.

Drs Aide Vega and Fernando Carnavali highlight the increased control in both diabetes and kidney function with the use of KidneyIntelX in patients with DKD.

Aida Vega, MD, and Fernando Carnavali, MD, discuss the KidneyIntelX study and the rates of referrals of high-risk DKD patients to specialist care.

Aida Vega, MD, and Fernando Carnavali, MD, review the population characteristics of a study involving the use of KidneyIntelX in DKD.

A diagnosis of concussion in an 8-year-old who plays weekend soccer is, on its face, bad news; the good news is that 15 years ago, it might have gone unnoticed, untreated.

GLP-1 RA side effects such as nausea and vomiting can be minimized by starting at the lowest available dose and titrating slowly; Dr Caroline Apovian explains why.

GLP-1 receptor agonist-based medications for obesity modify gut hormone imbalances, making diet and lifestyle change far more effective, explains Caroline Apovian, MD.

The vice president of the American Academy of Physical Medicine & Rehabilitation played a significant role in developing early concussion programs and educating clinicians and coaches.

Experts in diabetic nephropathy present a study of the use of the KidneyIntelX test in patients with DKD.

Experts review the role of the urinary albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) in current DKD progression screening practices.

Apovian: GLP-1 receptor agonists are the first antiobesity medications to simulate human physiology, which is why they sustain weight loss and are meant for long-term use.

Aida Vega, MD, and Fernando Carnavali, MD, discuss the limitations of the tools available to clinicians to screen for DKD, such as Kidney Disease: Improving Global Outcomes (KDIGO).

Fernando Carnavali, MD, comments on the prevalence of diabetic kidney disease (DKD) in the United States, the financial burden on patients and the healthcare system, as well as the importance of early detection of kidney disease in patients with diabetes.

Caroline Apovian, MD, highlights how drugs like semaglutide 2.4 mg treat the chronic relapsing disease of obesity and why a distinction from "weight-loss drugs" is critical.

A family physician and obesity medicine physician talks about chronic pain in patients with obesity.

An ongoing relationship with a primary care clinician is foundational to personal and community health and adults of color are less likely than White adults to have that.

Family physicians are positioned to identify at the patient level specific factors that contribute to and sustain disparities in health and US health care, says AAFP president.

Disparities in US health and health care delivery along some dimensions are moving backward, not forward, says AAFP president Iroku-Malize in this interview.

A sports medicine specialist talks about collaborating with primary care and says there are 3 things that help make the partnership work so well.